Answers are grounded in this paper and cite their sources.
Over the last decade, immune checkpoint inhibitors have revolutionized cancer patient treatment. However, not all patients benefit from these therapies. A major predictive factor of response to immune checkpoint inhibitors is immune infiltration at the tumor site. Although immune infiltration is dictated mostly by intrinsic tumor attributes, particularly the tumor mutational burden, intense research is ongoing to identify approaches to increase the homing of immune cells, especially of T cells, to the tumor. The aim of the present review was to provide an overview of the impact of physical activity on immune cell populations and on the perspectives of synergy with immune checkpoint inhibitors in cancer treatment. Physical activity is known to induce peripheral leukocytosis and has been shown to increase T and NK cell infiltration at the tumor site, suggesting that its combination with immune checkpoint inhibitors could be beneficial. Available literature on exercise immunity lacks homogeneity and this is identified as a gap for establishing strong evidence.
No takes yet. Share an insight, caveat, or question.
Latrille et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: